The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT)
Open accessAbstract
Background and Purpose— Based on previous studies comparing different recombinant tissue plasminogen activator (rt-PA) doses, we performed a clinical trial with 0.6 mg/kg, which is lower than the internationally approved dosage of 0.9 mg/kg, aiming to assess the efficacy and safety of alteplase in acute ischemic stroke for the Japanese. Methods— Our prospective, multicenter, single-arm, open-label trial was designed with a target sample size of 100 patients. The primary end points were the proportion of patients with a modified Rankin Scale (mRS) score of 0 to 1 at 3 months and the incidence of symptomatic intracranial hemorrhage (sICH) within 36 hours. Thresholds for these end points were determined by calculating 90% CIs of weighted averages derived from published reports. The protocol was defined according to the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA stroke study with slight modifications. Results— Among the 103 patients enrolled, 38 had an mRS of 0 to 1 at 3 months; this proportion (36.9%) exceeded the predetermined threshold of 33.9%. sICH within 36 hours occurred in 6 patients; this incidence (5.8%) was lower than the threshold of 9.6%. Conclusions— In patients receiving 0.6 mg/kg alteplase, the outcome and the incidence of sICH were comparable to published data for 0.9 mg/kg. These findings indicate that alteplase, when administered at 0.6 mg/kg to Japanese patients, might offer a clinical efficacy and safety that are compatible with data reported in North America and the European Union for a 0.9 mg/kg dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Barber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02237-6 · Cited by 2,668
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Albers, G. W., Bates, V. E., Clark, W. M., Bell, R., Verro, P., & Hamilton, S. A. (2000) · JAMA · doi:10.1001/jama.283.9.1145 · Cited by 700
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan, I. L., Furlan, A. J., Lloyd, L. E., Frank, J. I., Harper, D. L., Hinchey, J. A., Hammel, J. P., Qu, A., & Sila, C. A. (2000) · JAMA · doi:10.1001/jama.283.9.1151 · Cited by 648
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Brott, T. G., Haley, E. C., Levy, D. E., Barsan, W., Broderick, J., Sheppard, G. L., Spilker, J., Kongable, G. L., Massey, S., & Reed, R. (1992) · Stroke · doi:10.1161/01.str.23.5.632 · Cited by 545
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A., & Yamadori, A. (1992) · Neurology · doi:10.1212/wnl.42.5.976 · Cited by 472
Self-citationHaley, E. C., Levy, D. E., Brott, T. G., Sheppard, G. L., Wong, M. C., Kongable, G. L., Torner, J. C., & Marler, J. R. (1992) · Stroke · doi:10.1161/01.str.23.5.641 · Cited by 347
Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach
Grond, M., Stenzel, C., Schmülling, S., Rudolf, J., Neveling, M., Lechleuthner, A., Schneweis, S., & Heiss, W.-D. (1998) · Stroke · doi:10.1161/01.str.29.8.1544 · Cited by 246
Grotta, J. C., Burgin, W. S., El-Mitwalli, A., Long, M., Campbell, M., Morgenstern, L. B., Malkoff, M., & Alexandrov, A. V. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.2009 · Cited by 233
Treating Acute Stroke Patients With Intravenous tPA: The OSF Stroke Network Experience
Wang, D. Z., Rose, J. A., Honings, D. S., Garwacki, D. J., & Milbrandt, J. C. (2000) · Stroke · doi:10.1161/01.str.31.1.77 · Cited by 207
Tanne, D., Bates, V. E., Verro, P., Kasner, S. E., Binder, J. R., Patel, S. C., Mansbach, H. H., Daley, S., Schultz, L. R., Karanjia, P. N., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.424 · Cited by 178
Lopez-Yunez, A. M., Bruno, A., Williams, L. S., Yilmaz, E. Y., Zurrú, C., & Biller, J. (2001) · Stroke · doi:10.1161/01.str.32.1.12 · Cited by 158
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke
Yamaguchi, T., Hayakawa, T., & Kiuchi, H. (1993) · Cerebrovascular Diseases · doi:10.1159/000108714 · Cited by 152
Self-citationAnalysis of 16,922 Patients with Acute Ischemic Stroke and Transient Ischemic Attack in Japan
Kimura, K., Kazui, S., Minematsu, K., & Yamaguchi, T. (2004) · Cerebrovascular Diseases · doi:10.1159/000078749 · Cited by 145
Self-citationMagyar, M. T., Szikszai, Z., Balla, J., Valikovics, A., Kappelmayer, J., Imre, S. G., Balla, G., Jeney, V., Csiba, L., & Bereczki, D. (2003) · Stroke · doi:10.1161/01.str.0000048845.83285.ac · Cited by 142
Misdiagnosis of stroke in tissue plasminogen activator–treated patients
Scott, P., & Silbergleit, R. (2003) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(03)00443-8 · Cited by 131
Koennecke, H., Nohr, R., Leistner, S., & Marx, P. (2001) · Stroke · doi:10.1161/01.str.32.5.1074 · Cited by 117
Is the Benefit of Early Recanalization Sustained at 3 Months? A Prospective Cohort Study
Labiche, L. A., Al-Senani, F., Wojner, A. W., Grotta, J. C., Malkoff, M. D., & Alexandrov, A. V. (2003) · Stroke · doi:10.1161/01.str.0000055940.00316.6b · Cited by 112
One-Year Follow-Up in Acute Stroke Patients Treated With rtPA in Clinical Routine
Schmülling, S., Grond, M., Rudolf, J., & Heiss, W. (2000) · Stroke · doi:10.1161/01.str.31.7.1552 · Cited by 88
Normal Acquisition and Loss of Bone Mass
Abrams, S. A. (2003) · Hormone Research in Paediatrics · doi:10.1159/000074505 · Cited by 88
Efficacy of IV tissue plasminogen activator in acute stroke
Hsia, A. W., Sachdev, H., Tomlinson, J., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000071228.56362.36 · Cited by 86
Rymer, M. M., Thurtchley, D., & Summers, D. V. (2003) · Stroke · doi:10.1161/01.str.0000071107.66925.93 · Cited by 75
Policy developments in regulatory approval
Temple, R. (2002) · Statistics in Medicine · doi:10.1002/sim.1298 · Cited by 53
Dubey, N., Bakshi, R., Wasay, M., & Dmochowski, J. (2001) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2001.tb00031.x · Cited by 46
R1 - Systemic thrombolysis in German stroke units
Schenkel, J., Weimar, C., Knoll, T. M., Haberl, R. L., Busse, O., Hamann, G. F., Koennecke, H., & Diener, H. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1004-5 · Cited by 38
Alteplase not yet proven for acute ischaemic stroke
Bath, P. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)00039-7 · Cited by 32
Uchino, K., Alexandrov, A. V., Garami, Z. F., El‐Mitwalli, A., Morgenstern, L. B., & Grotta, J. C. (2005) · Cerebrovascular Diseases · doi:10.1159/000084090 · Cited by 15
Koster, R. W., Cohen, A. F., Kluft, C., Kasper, F. J., van der Wouw, P. A., & Weatherley, B. C. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.136 · Cited by 12
Cited by
Aoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000348552 · Cited by 1,929
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Campbell, B. C. V., & Khatri, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31179-x · Cited by 1,116
Suzuki, K., Matsumaru, Y., Takeuchi, M., Morimoto, M., Kanazawa, R., Takayama, Y., Kamiya, Y., Shigeta, K., Okubo, S., Hayakawa, M., et al. (2021) · JAMA · doi:10.1001/jama.2020.23522 · Cited by 545
Metadata
- Authors
- Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y.
- Venue
- Stroke
- Published
- 2006-07
- Volume
- 37
- Issue
- 7
- Pages
- 1810-1815
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2531503442
- Cited by
- 515
- References
- 32
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.